Business
4Cable TV International, Inc. (OTC.PK: CATV) Signs Letter of Intent to Acquire MariJ Pharmaceuticals from Branded Legacy, Inc. and Retains New Counsel for Name Change with FINRA
4Cable TV International, Inc. (OTC.PK: CATV) Signs Letter of Intent to Acquire MariJ Pharmaceuticals from Branded Legacy, Inc. and Retains New Counsel for Name Change with FINRA.
About this update from 4cable Tv International, Inc.
[{"type":"text","content":"4Cable TV International, Inc. (OTC.PK: CATV) Signs Letter of Intent to Acquire MariJ Pharmaceuticals from Branded Legacy, Inc. and Retains New Counsel for Name Change with FINRAMIAMI, Fla., Dec. 06, 2024 (GLOBE NEWSWIRE) -- 4Cable TV International, Inc. (OTC.PK: CATV), a leading innovator in emerging industries, is pleased to announce the signing of a Letter of Intent (LOI) to acquire MariJ Pharmaceuticals, Inc. from Branded Legacy, Inc. (OTC.PK: BLEG). This transformative LOI is expected to lead to an acquisition agreement that will bolster CATV’s position in the rapidly growing CBD and wellness sector through MariJ’s robust portfolio of licenses, certifications, and operational assets.MariJ Pharmaceuticals, based in Melbourne, Florida, specializes in certified organic CBD extraction and production, with patented processes, mobile extraction facilities, and a portfolio of award-winning products. The LOI outlines the intent to acquire MariJ’s compounding pharmacy license, state-of-the-art supercritical CO2 extraction equipment, certified organic refined CBD inventory, and a range of advanced tools and technologies. MariJ's assets also include a fleet of licensed and permitted vehicles, tailored for on-site extraction and refinement operations, which enhance geographic reach and service capabilities.The LOI includes provisions for the acquisition of MariJ’s intellectual property, operational databases, customer lists, trademarks, and organic certifications, as well as a patent for extraction and processing technology. CATV aims to integrate MariJ’s proven formulations and products into its expanding wellness-focused portfolio following the completion of the acquisition agreement.Strengthening Corporate Structure with New Legal Counsel In addition to this strategic LOI, CATV has retained a seasoned SEC attorney to oversee and expedite its corporate name change filing with FINRA to \"Category V Biotech, Inc.\" This move is part of the company’s broader strategy to align its branding with its evolving business operations and growth trajectory.David Oswald, CEO of MariJ Pharmaceuticals, shared his optimism:\"As I step away from MariJ Pharmaceuticals to focus on growing Sycamore Biopharma, which requires the full attention of me and my team, I am confident that Michael Feldenkrais and his team will do wonderful things with MariJ. This...